Dr. Kayse Shrum

Dr. Kayse Shrum Mom to 6 · Grandma “Gucci” to 1 · “Mommy Shrum” to many · Mentor at heart · Lover of shoes · Proud Oklahoman

🌿Wellness Wednesday: Feeling disappointed?Have you ever felt like you show up for people in ways they never seem to show...
06/03/2026

🌿Wellness Wednesday: Feeling disappointed?

Have you ever felt like you show up for people in ways they never seem to show up for you?

Maybe you’re the one who remembers birthdays, sends encouraging texts, gives thoughtful gifts, offers wise counsel, or notices when someone is struggling. When those things aren’t returned, it’s easy to feel unseen, unimportant, or undervalued.

But what if the issue isn’t that people don’t care?

What if God has simply gifted you differently?

Scripture teaches that God gives each of us unique gifts. The Bible identifies many spiritual gifts. Some are gifted with encouragement. Some with hospitality. Some with compassion. And so on…..

Sometimes we become disappointed because we expect others to show up the same way we show up for them.

If giving encouragement is your gift, you may naturally crave encouraging words. If giving gifts is your gift, thoughtful gifts may mean a great deal to you. We often value most highly the very things we freely give away.

Before assuming someone doesn’t care, ask yourself:

“Are they withholding their gift from me, or am I expecting them to have the same gift I have?”

God gave you a gift not because He intended for everyone to give it back to you, but because He intended for you to use it to bless others.

So be careful not to take every situation personally. Look for the gifts people are offering, even when they look different than the ones you give.

And be grateful for every gift you receive.

After all, the body of Christ was never designed so that everyone would be the same. It was designed so that each of us would bring something unique to the table.

Sometimes the very thing that frustrates you is evidence of the gift God placed within you. You notice what others miss because that’s how He wired you. You give encouragement because you understand the power of being encouraged. You show compassion because you understand what it feels like to need it. Your gift isn’t just something you do—it’s often born from what God has done in you.

Your gift has a PURPOSE! And so does theirs!

Perspective matters!

I will not mention names BUT someone dropped their phone today and it broke! Same person doesn’t have data backed up so ...
06/02/2026

I will not mention names BUT someone dropped their phone today and it broke! Same person doesn’t have data backed up so we have to get the phone fixed to get the data. If you usually text or call my husband, he will be phone free until Thursday! If it’s an emergency…..you know where to find me!

Just living the good life. Beach Day #2 BUT first……Arm Day! Work Hard- Play Hard!
06/01/2026

Just living the good life. Beach Day #2 BUT first……Arm Day! Work Hard- Play Hard!

05/31/2026

Toes in the water…….

🌿Wellness Wednesday: Peptides Part 3There is a LOT of discussion right now around Retatrutide — and not just because of ...
05/28/2026

🌿Wellness Wednesday: Peptides Part 3

There is a LOT of discussion right now around Retatrutide — and not just because of the remarkable weight loss data.

Retatrutide is a triple agonist, meaning it targets:

* GLP-1
* GIP
* Glucagon receptors

In early trials, it has shown weight loss approaching bariatric surgery levels in some patients.

But behind the scenes, there is another major battle happening:
How should Retatrutide be classified?

Eli Lilly and Company has been arguing that Retatrutide should potentially be classified as a biologic rather than a traditional peptide drug.

Why does that matter?

Because biologics are regulated differently than standard drugs:

* Longer exclusivity protections
* Different manufacturing standards
* More restrictions on compounding
* Greater barriers to generic or copycat competition

In simple terms:
If Retatrutide ultimately receives biologic-type protection, it could significantly limit future compounding and keep costs very high for patients.

That is why this conversation matters to the general public.

For patients, this debate is really about:

* Access
* Affordability
* Safety
* Innovation
* And who controls the future of these therapies

Supporters of Lilly’s position argue:

* these are highly complex molecules,
* manufacturing consistency matters,
* and stricter oversight protects patients.

Critics argue:

* biologic-style protections may reduce affordability,
* limit access,
* and prevent compounded alternatives that many patients rely on during shortages or due to cost.

The FDA has not made a final determination, and legal challenges are still ongoing.

05/24/2026

708,771 minutes ago…
we all happily joined PST — Palmer Standard Time. 💙
From the moment I held you for the first time…
to 16 months of smiles, snuggles, milestones, and pure joy.
Life just got sweeter when you arrived. ✨

05/22/2026

34 years… and still my favorite person. ❤️

Manly enough to build me a deck.
Secure enough to join me for pedicures.
Strong enough to be my workout partner.
Gentle enough to be the very best “Dude” to our Palmer.
Patient enough to be my husband and best friend.
And steady enough to be my protector through every season of life.

Life has given us laughter, challenges, blessings, and more memories than I can count—but through it all, God has been faithful.

“Though one may be overpowered, two can defend themselves. A cord of three strands is not quickly broken.”
— Ecclesiastes 4:12

So thankful for a marriage built on faith, friendship, strength, and love.

Happy Anniversary, Darren. ❤️ 34 years and still grateful God wrote our story together.

Wellness Wednesday: Peptides Part 2Robert F. Kennedy Jr. has publicly discussed expanding access to certain compounded p...
05/20/2026

Wellness Wednesday: Peptides Part 2

Robert F. Kennedy Jr. has publicly discussed expanding access to certain compounded peptides and reconsidering FDA restrictions that were put in place in 2023. The issue centers primarily around peptides that had been placed on the FDA’s “Category 2” bulk substances list, which effectively prevented traditional compounding pharmacies from preparing them.

The peptides most commonly discussed in reports and industry coverage include:

* BPC-157
* CJC-1295
* Ipamorelin
* Thymosin Alpha-1
* AOD-9604
* Selank
* GHK-Cu

These compounds are popular in wellness, recovery, anti-aging, metabolic health, and sports-performance communities, but most are not FDA-approved drugs for those uses.

Kennedy’s argument appears to be:

* people are already using these peptides,
* banning legal compounding pushes patients toward unregulated “research chemical” markets,
* licensed compounding pharmacies are safer than gray-market internet sourcing,
* and some peptides show enough promise to justify broader physician-supervised access while more research develops.

Critics—including some FDA and public health experts—argue that many of these peptides still lack:

* large randomized clinical trials,
* long-term safety data,
* manufacturing consistency data,
* and clear efficacy evidence.

As for whether this has actually advanced: yes, somewhat—but it is not finalized policy.

What has happened:

* FDA advisory committee meetings were scheduled for July 2026 to reconsider several restricted peptides.
* FDA is reportedly reviewing whether certain peptides should move back to “Category 1,” which would again allow traditional compounding under physician prescription.
* Public statements from Kennedy and HHS have clearly signaled support for loosening restrictions.

What has not happened:

* There has not yet been broad formal FDA approval of these peptides.
* Most still do not have large Phase III-style clinical trial evidence.
* Final FDA reclassification decisions are still pending.

Medicine often evolves this way. Early observations generate interest, formal trials follow, safety signals emerge over time, and eventually some therapies become mainstream while others fall away.

That was true for:

* GLP-1 medications,
* hormone therapies,
* biologics,
* immunotherapies,
* and many cardiovascular drugs.

The key tension right now is balancing:

* innovation,
* patient access,
* affordability,
* quality control,
* and evidence-based medicine.

And peptides are sitting directly in the middle of that debate.

05/20/2026

Family time at the Coweta Crawfish Boil ❤️🦞
Now, to be clear… I’m not there for the crawfish. 😂 I’m there for the people, the atmosphere, the live music, and the kind of small-town Main Street moments that just feel special. Nothing better than a community coming together and time spent with the people you love most. ✨

&dude

05/16/2026

Feeding the fish! 🐟

Address

1530 Main St
Dallas, TX
75201

Website

Alerts

Be the first to know and let us send you an email when Dr. Kayse Shrum posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category